Multivariate Cox regression analysis confirmed that ZNF148 is an independent prognostic marker, suggesting that it may facilitate tumor progression and serve as a valuable biomarker for predicting clinical outcomes in ESCC patients [19]. The gene discussed is ZNF148; the disease is neoplasm.